Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Monitoring vital signs in patients using long-term oxygen therapy

Official title: Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial

Run by University of Sao Paulo General Hospital · NCT06882265 · Data updated 2026-11-12

This study tests if using a wearable device to monitor vital signs can improve the quality of life for adults with COPD and interstitial lung disease who are on long-term oxygen therapy.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Sao Paulo General Hospital
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedNovember 10, 2024
Main results expectedJuly 30, 2025
Study endsDecember 15, 2025
Registry record updatedMarch 18, 2025
Trial IDNCT06882265 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with stable COPD or ILD who are on optimized drug therapy and long-term oxygen therapy.

Probably not a fit

Patients with other significant lung diseases or severe heart conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the quality of life in adults with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) who are on long-term oxygen therapy. Participants will be randomized into two groups: one receiving continuous monitoring through a wearable device for 90 days, and the other receiving a standard pulse oximeter. Both groups will have their vital signs monitored via a mobile application to assess the impact of remote monitoring on their health outcomes.

Why it matters

Potential benefit: If successful, this study could enhance the quality of life for patients on long-term oxygen therapy by providing better monitoring and management of their condition.

How similar studies have gone: Other studies have shown promise in using remote monitoring for chronic respiratory conditions, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines;
* Age over 18 years;
* Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
* Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT)
* Have a smartphone compatible with the monitoring device;
* Signing of the ICF to participate in the study.

Exclusion Criteria:

* Presence of other concomitant lung diseases;
* Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated.
* Patients who received a lung transplant during the study
* Living outside the coverage area or moving out of state

Where it's running

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP),
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.